not logged in

European Urology

Inpress

Note to users:

This section contains peer reviewed, accepted articles to be published in the journal. When an article is assigned to an issue, the "Articles In Press" version will be removed from this section. "Articles In Press" consist of:

  • Uncorrected proofs: articles that are not finalized and that will be corrected by the authors. Uncorrected proofs may be temporarily unavailable for production reasons.
  • Corrected proofs: articles that contain the authors' corrections but typically have not been assigned issue and page numbers.

Viewing articles 61-70 of 214


  Three-year Oncologic and Renal Functional Outcomes After Robot-assisted Partial Nephrectomy Three-year Oncologic and Renal Functional Outcomes After Robot-assisted Partial Nephrectomy

Ali Khalifeh, Riccardo Autorino, Remi Eyraud, Dinesh Samarasekera, Humberto Laydner, Kamol Panumatrassamee, Robert J. Stein and Jihad H. Kaouk

16 April 2013

0

Abstract Full Text Full-Text PDF (633 KB)

Corrected

Create Platinum Slide Series

Re: Markus Graefen, Thorsten Schlomm. Active Surveillance for Low-risk Prostate Cancer: Some Questions Are Answered, but Many Questions Remain. Eur Urol 2013;63:604–5

Diederik M. Somford

16 April 2013

0

Full Text Full-Text PDF (121 KB)

Corrected


Reply to Chris Cardwell, Samy Suissa and Liam J Murray's Letter to the Editor Re: Helene H Grytli, Morten W Fagerland, Sophie D Fosså et al. Association Between Use of β-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007

Helene Hartvedt Grytli, Morten W. Fagerland, Sophie D. Fosså and Kristin Austlid Taskén

16 April 2013

0

Full Text Full-Text PDF (126 KB)

Uncorrected


Reply from Authors re: David F. Penson. Post-prostatectomy Incontinence and Pelvic Floor Muscle Training: A Defining Problem. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.009

Inge Geraerts, Hendrik Van Poppel and Marijke Van Kampen

16 April 2013

0

Full Text Full-Text PDF (132 KB)

Corrected


  OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Christopher Chapple, Karl-Dietrich Sievert, Scott MacDiarmid, Vik Khullar, Piotr Radziszewski, Christopher Nardo, Catherine Thompson, Jihao Zhou and Cornelia Haag-Molkenteller

16 April 2013

0

Abstract Full Text Full-Text PDF (495 KB)

Corrected

Create Platinum Slide Series

  Long-term Outcomes of Patients with Lymph Node Metastasis Treated with Radical Prostatectomy Without Adjuvant Androgen-deprivation Therapy Long-term Outcomes of Patients with Lymph Node Metastasis Treated with Radical Prostatectomy Without Adjuvant Androgen-deprivation Therapy

Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino and James A. Eastham

16 April 2013

0

Abstract Full Text Full-Text PDF (697 KB)

Corrected

Create Platinum Slide Series

Interpreting a Study on Bladder Cancer Screening

Brant A. Inman and Michael R. Abern

16 April 2013

0

Full Text Full-Text PDF (147 KB)

Corrected


  Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group

Fernando Calais da Silva, Fernando Manuel Calais da Silva, Frederico Gonçalves, Américo Santos, Jan Kliment, Peter Whelan, Tim Oliver, Nicos Antoniou, Spiro Pastidis, Anton Marques Queimadelos and Chris Robertson

16 April 2013

0

Abstract Full Text Full-Text PDF (284 KB)

Corrected

Create Platinum Slide Series

  A Novel Model of Urinary Tract Differentiation, Tissue Regeneration, and Disease: Reprogramming Human Prostate and Bladder Cells into Induced Pluripotent Stem Cells A Novel Model of Urinary Tract Differentiation, Tissue Regeneration, and Disease: Reprogramming Human Prostate and Bladder Cells into Induced Pluripotent Stem Cells

Mohammad Moad, Deepali Pal, Anastasia C. Hepburn, Stuart C. Williamson, Laura Wilson, Majlinda Lako, Lyle Armstrong, Simon W. Hayward, Omar E. Franco, Justin M. Cates, Sarah E. Fordham, Stefan Przyborski, Jane Carr-Wilkinson, Craig N. Robson and Rakesh Heer

16 April 2013

0

Abstract Full Text Full-Text PDF (2,4 MB)

Online Extra

Corrected

Create Platinum Slide Series

  Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08) Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08)

Arnoud J. Templeton, Valérie Dutoit, Richard Cathomas, Christian Rothermundt, Daniela Bärtschi, Cornelia Dröge, Oliver Gautschi, Markus Borner, Eva Fechter, Frank Stenner, Ralph Winterhalder, Beat Müller, Ralph Schiess, Peter J. Wild, Jan H. Rüschoff, George Thalmann, Pierre-Yves Dietrich, Ruedi Aebersold, Dirk Klingbiel and Silke Gillessen on behalf of the Swiss Group for Clinical Cancer Research (SAKK).

16 April 2013

0

Abstract Full Text Full-Text PDF (816 KB)

Online Extra

Corrected

Create Platinum Slide Series

Viewing articles 61-70 of 214